200405 - An observational retrospective database analysis to estimate the risk of Multiple Sclerosis (MS) following vaccination with Arepanrix™ in Manitoba, Canada

01/10/2014
23/04/2024
EU PAS number:
EUPAS6817
Study
Finalised
Subscribe
Download as PDF
Documents
Study protocol
Initial protocol

200405-protocol-redact

English (344.83 KB - PDF) View document
Study results
Study results

gsk-200405-clinical-study-report-redact

English (1.4 MB - PDF) View document

gsk-200405-clinical-study-report-redact_2

English (2.13 MB - PDF) View document
Study report
Other information